INTERPRETING PSYCHOSOCIAL FUNCTIONING IN INDIVIDUALS USING NON-INJECTABLE OPIOIDS

Abstract

Background: Individuals diagnosed with opioid use disorder (OUD) exhibit a notable disruption in their
psychosocial functioning and related areas. In India, there is a dearth of research on these issues with psychosocial
functioning in opioid use disorder.
Aim: The purpose of the current study was to evaluate the psychosocial functioning of participants receiving standard
treatment for non-injectable opioid use (buprenorphine, tapentadol, tramadol, trazodone, zolpidem, and
chlordiazepoxide) before switching to methadone maintenance therapy (MMT).
Methods: 134 non-injecting patients with opioid use disorder who had received MMT (n = 74) or therapy as usual (n
= 60) for at least one month were evaluated in this cross-sectional research.
The WHO and the Alcohol, Smoking, and Substance Involvement Screening Test 3.0 were utilised to evaluate the
individuals' comorbidities and degree of disease. The WHO Quality of Life (WHOQoL BREF), the Client
Satisfaction Questionnaire (CSQ 8), and the Social and Occupational Functioning Assessment Scale (SOFAS) were
used to measure client satisfaction, QoL, and socio-occupational functioning, respectively.